Patients with type ii autoimmune hepatitis express functionally intact cytochrome P‐450 db1 that is inhibited by LKM‐1 autoantibodies in vitro but not in vivo
Michael Manns, Ulrich Zanger, Guido Gerken, Kevin F. Sullivan, Karl‐H. Meyer Zum Büschenfelde, Urs A. Meyer, Michel Eichelbaum – 1 July 1990 – Liver‐kidney microsomal‐1 autoantibodies characterize a subgroup of autoimmune chronic active hepatitis. The liver antigen of liver‐kidney microsomal‐1 antibodies has been identified as cytochrome P450 db1, a microsomal enzyme catalyzing the oxidative metabolism of more than 20 drugs, including debrisoquine, sparteine and bufuralol.